STERIS plc Restructuring and Related Cost, Accelerated Depreciation
STERIS plc (STE) reported Restructuring and Related Cost, Accelerated Depreciation of $0 for the 12-month period ending 2020-03-31, per its 8-K filed 2021-02-09.
Discontinued › Notes
us-gaap:RestructuringReserveAcceleratedDepreciation · last filed 2021-02-09
| Period end | Restructuring and Related Cost, Accelerated Depreciation 12 month |
|---|---|
| 2020-03-31 | $0.00 8-K · filed 2021-02-09 |
| 2019-03-31 | $16.19M 8-K · filed 2021-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |